Statin drugs and the risk of fracture.
El-Sohemy
A
A
D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D002792:Cholestyramine Resin / Q000494:pharmacology; D050723:Fractures, Bone / Q000453:epidemiology*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology*; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D017035:Pravastatin / Q000494:pharmacology*; D012306:Risk; D016212:Transforming Growth Factor beta
C525718:BMP2 protein, human; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D016212:Transforming Growth Factor beta; D002792:Cholestyramine Resin; D017035:Pravastatin